RESUMO
Streptomyces sp. KM1-30 was isolated from soil as a producer of antimutagens by screening with a modified Ames test. The chemical structure of the antimutagenic metabolite was identified as streptovaricin C, which is known to inhibit DNA dependent RNA polymerase from E. coli and RNA dependent DNA polymerase from RNA tumor viruses, by MS and 1H-, 13C-NMR analyses. Addition of streptovaricin C to the cultures of UV treated Salmonella typhimurium TA100 or Trp-P-2-treated S. typhimurium TA98 decreased the frequency of mutation without a decrease in viable cell counts. The effect of streptovaricin C to the mutation induced by UV and Trp-P-2 was not desmutagenic, but antimutagenic.
Assuntos
Antimutagênicos/isolamento & purificação , Streptomyces/química , Estreptovaricina/análogos & derivados , Actinomycetales/efeitos dos fármacos , Actinomycetales/genética , Antimutagênicos/química , Antimutagênicos/farmacologia , Estrutura Molecular , Testes de Mutagenicidade , Estreptovaricina/química , Estreptovaricina/isolamento & purificação , Estreptovaricina/farmacologiaRESUMO
Transcription by RNA polymerase II occurs after formation of a transcription complex. This complex is assembled in stages by the interaction of transcription factors with the template and/or with each other. We report on the ability of six drugs to inhibit the assembly of the RNA polymerase II transcription complex. Assembly of the complex on the adenovirus major late promoter requires several transcription factors. The normal assembly process requires that the DNA first interact with TFIIA, then with TFIID, and finally with at least four additional transcription factors (one of which is RNA polymerase II). We observed that streptolydigin (10 micrograms/ml) inhibits association of ILA and IID, and at higher concentrations (100 micrograms/ml) inhibits that IIA/IID complex from binding to DNA. Streptovaricin (100 micrograms/ml) appears to inhibit the IIA/IID interaction with DNA and prevents reinitiation (at 500 micrograms/ml). Adriamycin (1 microgram/ml) inhibits the interaction of TFIID with the IIA/DNA complex and inhibits an additional event immediately prior to, or during, elongation. Daunorubicin may be an elongation inhibitor. Heparin at 10 micrograms/ml inhibits further assembly after the IIA/IID/DNA complex has formed, and at 100 micrograms/ml also inhibits a late event in the assembly process and blocks reinitiation. Rifamycin AF/013 (100 micrograms/ml) inhibits the early events necessary to form the IIA/IID/DNA complex and (at 10 micrograms/ml) an assembly event following formation of the IIA/IID/DNA complex. Therefore, these compounds should be useful as probes for further examination of the assembly process.
Assuntos
Aminoglicosídeos , RNA Polimerase II/genética , Antibacterianos/farmacologia , Daunorrubicina/farmacologia , Doxorrubicina/farmacologia , Células HeLa , Heparina/farmacologia , Humanos , Rifamicinas/farmacologia , Estreptovaricina/farmacologia , Transcrição Gênica/efeitos dos fármacosRESUMO
n-Pentyl ether of damavaricin Fc (n-pentyl DvFc) preferentially killed human T-cell lymphotropic virus type I (HTLV-I)-transformed cell lines. The mechanism of action of the drug was investigated using MT-4 cells. Cytotoxic action was diminished by the removal of n-pentyl DvFc from the culture or by the addition of sulfhydryl compounds such as 2-mercaptoethanol and dithiothreitol. The killing activity of n-pentyl DvFc was also diminished by membrane-acting agents including quinidine and diphenylhydantoin. Influx and subsequent efflux of Ca2+ were observed when either HTLV-I infected (MT-4 cells) or uninfected cells were treated with n-pentyl DvFc. An efflux of K+ was observed in HTLV-I infected MT-4 cells immediately after the exposure of the cells to n-pentyl DvFc. The K+ efflux, however, was not observed in the uninfected T cells. n-Pentyl DvFc seems to act primarily on the cell surface of MT-4 cells, leading to the perturbation of membrane function. The restoration of cell growth, however, is critically dependent on the presence of dithiothreitol and 2-mercaptoethanol, implying a role for a free sulfhydryl group in the killing activity.
Assuntos
Antivirais/farmacologia , Vírus Linfotrópico T Tipo 1 Humano , Estreptovaricina/farmacologia , Linfócitos T/efeitos dos fármacos , Antibacterianos , Antivirais/uso terapêutico , Cálcio/metabolismo , Linhagem Celular Transformada , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Permeabilidade da Membrana Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Transformação Celular Neoplásica , Transformação Celular Viral , DNA/biossíntese , Ditiotreitol/farmacologia , Humanos , Leucemia de Células T/tratamento farmacológico , Leucemia de Células T/patologia , Mercaptoetanol/farmacologia , Fenitoína/farmacologia , Potássio/metabolismo , Quinidina/farmacologia , Estreptovaricina/uso terapêutico , Linfócitos T/metabolismo , Linfócitos T/microbiologiaAssuntos
Antibióticos Antineoplásicos , Antivirais , Estreptovaricina/farmacologia , Animais , Bactérias/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular Transformada , Fenômenos Químicos , Química , Humanos , Estrutura Molecular , Células Tumorais Cultivadas/efeitos dos fármacos , Vírus/efeitos dos fármacosRESUMO
We investigated the effects of six drugs on an RNA polymerase III in vitro transcription system. Adriamycin, daunorubicin, heparin, rifamycin AF/013, streptolydigin, and streptovaricin all inhibit RNA synthesis from a tRNA gene or the adenovirus 2 (AD2) VA1 RNA gene. The completed RNA polymerase III transcription complex is formed by the sequential, ordered addition of protein factors. Although both genes reportedly use the same transcription fractions for in vitro RNA synthesis, some of these drugs interfere differentially with these genes. A drug concentration that inhibits transcription from one gene may not inhibit transcription from the other gene. Adriamycin seems to block transcription if added between the binding of the individual transcription fractions. Daunorubicin appears to inhibit VA transcription only if added prior to both transcription fractions, but inhibits tRNA synthesis before and during transcription factor binding. Heparin blocks both genes between factors binding to DNA and after factor binding. Rifamycin blocks VA synthesis more effectively than tRNA synthesis. Streptolydigin blocks transcription of both genes. Streptovaricin probably blocks transcription by inhibiting early transcription complex assembly events. These drugs appear useful as appropriate probes to investigate transcription complexes since several discriminate between complexes formed on different genes during the assembly process.
Assuntos
Aminoglicosídeos , Antibacterianos/farmacologia , RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , RNA Polimerase III/antagonistas & inibidores , Transcrição Gênica/efeitos dos fármacos , Adenovírus Humanos/genética , Citosol/enzimologia , Daunorrubicina/farmacologia , Doxorrubicina/farmacologia , Genes/efeitos dos fármacos , Genes Virais/efeitos dos fármacos , Células HeLa/enzimologia , Heparina/farmacologia , Humanos , Rifamicinas/farmacologia , Estreptovaricina/farmacologiaRESUMO
A DNA-membrane complex extracted from Bacillus subtilis was studied further as a model system for initiation of bacterial DNA replication in vitro. Of three subcomplexes purified from the crude complex by a combination of CsCl and sucrose gradient centrifugation, the synthetic capability of only one was inhibited significantly by streptovaricin, a known inhibitor of RNA primer formation. A selective enrichment in the level of this subcomplex was obtained by manipulating a thymine-requiring mutant. The synthetic capabilities of an enriched and nonenriched DNA-membrane complex were compared in the presence and absence of streptovaricin. Although the rate and extent of DNA synthesis per unit of protein were approximately the same in the absence of the antibiotic, there was a much greater inhibition of synthesis shown by the enriched complex in the presence of streptovaricin. Although the amount of DNA present in the putative initiation subcomplex was less than 0.3 to 0.4% of the total DNA present in the crude complex, such DNA, except for a few quantitative differences, was still representative of genomic DNA. Newly synthesized DNA hybridized to specific origin- and non-origin-derived restriction fragments of the B. subtilis genome. However, when an elongation inhibitor (ddCTP) was added, hybridization of such DNA to almost all of the nonorigin fragments disappeared or was reduced drastically, whereas origin region hybridization patterns remained strong. The highest level of hybridization in the origin region occurred with a BamHI (B7) restriction fragment of 5.6 kilobases that has been implicated by others as one site initiation in vivo (N. Ogasawara, M. Seiki, and H. Yoshikawa, Nature (London) 281:702-704, 1979; S. J. Seror-Laurent and G. Henckes, Proc. Natl. Acad. Sci. USA 82:3586-3590, 1985).
Assuntos
Bacillus subtilis/genética , Replicação do DNA , DNA Bacteriano/fisiologia , Fracionamento Celular , Membrana Celular/fisiologia , Centrifugação com Gradiente de Concentração , Mapeamento Cromossômico , Clonagem Molecular , Replicação do DNA/efeitos dos fármacos , Técnicas In Vitro , Substâncias Macromoleculares , Hibridização de Ácido Nucleico , Estreptovaricina/farmacologia , Moldes GenéticosRESUMO
A bovine polymorphonuclear leukocyte (PMN) monolayer system was used to determine the ability of different antibiotics to kill surviving intracellular Staphylococcus aureus. The following classes of antimicrobial agents were tested in this high-volume assay procedure: aminocyclitol, beta-lactam, coumarin, lincosaminide, macrolide, naphthalenic ansamycin, paulomycin, peptide, quinolone, and tetracycline. The activities of these compounds were compared with those of positive (rifampin), negative (cloxacillin), and non-antibiotic-treated controls. Only oxytetracycline, the ansamycins (rifampin, rifamycin SV, streptovaricin A, C, and D), paulomycin, and paldimycin caused a significant reduction in the viable count of intracellular S. aureus. Of these, however, the intracellular killing by the streptovaricins was directly related to the cytotoxicity (as determined by trypan blue exclusion) of these compounds for the PMNs. Although the paulomycins were cytotoxic for the PMNs, the cytotoxic and the intracellular killing activity of these new compounds could be distinguished. The relevance of these results to the therapeutic effectiveness of these antibiotics in the treatment of bovine staphylococcal mastitis is discussed.
Assuntos
Antibacterianos , Neutrófilos/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Animais , Bovinos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Testes de Sensibilidade Microbiana , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Estreptovaricina/farmacologiaAssuntos
Antibacterianos/farmacologia , Antivirais/farmacologia , Cefalosporinas/farmacologia , DNA Viral/antagonistas & inibidores , Dactinomicina/farmacologia , Interações Medicamentosas , Indutores de Interferon/farmacologia , Lipídeos de Membrana/farmacologia , Polienos/farmacologia , RNA Viral/antagonistas & inibidores , Rifamicinas/farmacologia , Estreptovaricina/farmacologia , Relação Estrutura-Atividade , Proteínas Virais/antagonistas & inibidores , Vírion/efeitos dos fármacos , Replicação Viral/efeitos dos fármacosRESUMO
Resistance to the endogenous antibiotic was studied in three actinomycetes that produce inhibitors of RNA polymerase. The three producers, Nocardia mediterranei (rifamycin producer), Streptomyces spectabilis (streptovaricin producer) and Streptomyces lydicus (streptolydigin producer), were each highly resistant to the antibiotic they produce (MIC greater than 200 micrograms ml-1) and in vivo RNA synthesis was also resistant. However, cross-resistance to the other RNA polymerase inhibitors was not found. Resistance to these antibiotics was due to target site modification, since the RNA polymerase enzymes of the three producing organisms were highly resistant in vitro to the corresponding antibiotic, and no antibiotic-inactivating enzymes were detected. A mutant was isolated from S. spectabilis which was sensitive to steptovaricin (its own product) and also showed an increased sensitivity to rifamycin and streptolydigin. This mutant had RNA polymerase which was extremely sensitive to the three antibiotics.
Assuntos
Actinomycetales/metabolismo , Aminoglicosídeos , RNA Polimerases Dirigidas por DNA/antagonistas & inibidores , Actinomycetales/efeitos dos fármacos , Antibacterianos/biossíntese , Antibacterianos/farmacologia , RNA Polimerases Dirigidas por DNA/metabolismo , Resistência Microbiana a Medicamentos , Nocardia/efeitos dos fármacos , Nocardia/metabolismo , RNA Bacteriano/biossíntese , Rifamicinas/biossíntese , Rifamicinas/farmacologia , Streptomyces/efeitos dos fármacos , Streptomyces/metabolismo , Estreptovaricina/biossíntese , Estreptovaricina/farmacologiaRESUMO
Initiation of DNA replication has been observed in vitro with a DNA-membrane complex extracted from Bacillus subtilis. Antibiotics known to interfere with various aspects of initiation inhibited DNA synthesis significantly in vitro, whereas a mutant resistant to one inhibitor failed to respond to its presence. The inhibitory effects occurred primarily when the immediate RNA precursors (ribonucleoside triphosphates) were present in the assay solution but not significantly when the precursors were omitted. Complexes extracted from a temperature-sensitive initiation mutant were almost incapable of synthesizing DNA at the restrictive temperature but displayed extensive synthesis at the permissive temperature. A strong indication of semiconservative DNA synthesis was obtained in vitro after density-shift experiments involving incubation of the complex with a heavy-density DNA precursor, followed by neutral and alkaline CsCl density gradient centrifugation. A significant amount of chain elongation or repair (or both) was also observed.
Assuntos
Aminoglicosídeos , Bacillus subtilis/metabolismo , Replicação do DNA , DNA Bacteriano/biossíntese , Antibacterianos/farmacologia , Membrana Celular/fisiologia , Replicação do DNA/efeitos dos fármacos , DNA Bacteriano/genética , Ácido Nalidíxico/farmacologia , Estreptovaricina/farmacologiaRESUMO
Fourteen streptovaricin derivatives were tested for inhibition of cellular nucleotide polymerases (deoxyribonucleic acid polymerases alpha, beta, and gamma, terminal deoxynucleotidyltransferase [TdT], and ribonucleic acid polymerase II), simian sarcoma virus deoxyribonucleic acid polymerase, and herpes simplex virus type 1-induced deoxyribonucleic acid polymerase (HSV-DP). Three compounds (strep-tovadienal C, prestreptovarone, and streptoval Fc) preferentially inhibited TdT and HSV-DP over the other enzymes. These compounds inhibited HSV-DP more potently than they inhibited TdT. Evidence indicated that the mode of inhibition of TdT and HSV-DP by streptovadienal C and prestreptovarone was by interaction with the enzymes and not with template-primer, initiator, substrates, or divalent cations required for enzyme activity. Furthermore, data suggested that these compounds bind with greater affinity to HSV-DP than to TdT. Streptovadienal C and prestreptovarone were examined for their effect on the replication of herpes simplex virus type 1 in African green monkey kidney (CV1) cells. These compounds produced 2- and 3-log drops in virus titer, respectively, at concentrations not significantly affecting cell viability. This correlated with evidence indicating a greater binding affinity of these compounds for HSV-DP over cellular nucleotide polymerases.
Assuntos
Antivirais , Nucleotidiltransferases/antagonistas & inibidores , Simplexvirus/efeitos dos fármacos , Estreptovaricina/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Chlorocebus aethiops , Rim , Fatores de TempoAssuntos
Antibacterianos , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Fenômenos Químicos , Química , Maitansina/farmacologia , Conformação Molecular , Naftoquinonas/farmacologia , Quinonas/farmacologia , Rifamicinas/farmacologia , Estreptovaricina/farmacologia , Relação Estrutura-AtividadeAssuntos
Vírus do Sarcoma Murino/efeitos dos fármacos , Estreptovaricina/farmacologia , Animais , Agregação Celular/efeitos dos fármacos , Células Cultivadas , Depressão Química , Vírus da Leucemia Murina/efeitos dos fármacos , Vírus da Leucemia Murina/crescimento & desenvolvimento , Ratos , Vírus do Sarcoma Murino/crescimento & desenvolvimento , Relação Estrutura-AtividadeRESUMO
Spontaneous mutants of Staphylococcus aureus resistant to rifampin, rifamycin SV, streptovaricin, or streptolydigin were isolated and shown to be resistant due to chromosomal rather than plasmid mutations. Based on data concerning spontaneous mutation rates, genetic cotransduction rates, and in vitro sensitivity studies, four major antibiotic cross-resistance patterns were found. The genetic markers responsible for these cross-resistance patterns were shown to be separable by transduction. Nonpurified RNA polymerase activity in lysates of mutants showed the same sensitivity to these antibiotics as shown by the mutants on solid media. A model is proposed explaining possible structure-function relationships involved in the binding of these antibiotics to the RNA polymerase molecule and the mutations resulting in resistance to these antibiotics. This model includes generally overlapping but different-sized binding sites on the RNA polymerase protein coded for by similarly arranged mutable sites on the DNA.
Assuntos
Antibacterianos/farmacologia , RNA Polimerases Dirigidas por DNA/metabolismo , Genes , Staphylococcus aureus/genética , Aminoglicosídeos , Resistência Microbiana a Medicamentos , Mutação , Rifampina/farmacologia , Rifamicinas/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/enzimologia , Estreptovaricina/farmacologiaRESUMO
DNA-dependent RNA and polyadenylic acid polymerases have been purified from phototrophic Rhodospirillum rubrum. Their properties have been found to be very similar to those of the previously reported heterotrophic R. rubrum enzymes. However, several important differences do exist between the enzymes from the phototrophic and the heterotrophic cells, such as the lack of response to added polyadenylic acid for poly A synthesis and the presence of the sigma subunit in the phototrophic enzymes. Furthermore, additional purification steps were necessary for preparation of phototrophic enzyme fractions with high DNA-dependence.
Assuntos
RNA Polimerases Dirigidas por DNA , Nucleotidiltransferases , Polinucleotídeo Adenililtransferase , Rhodospirillum rubrum/enzimologia , RNA Polimerases Dirigidas por DNA/isolamento & purificação , RNA Polimerases Dirigidas por DNA/metabolismo , Luz , Nucleotidiltransferases/isolamento & purificação , Poli A/biossíntese , Polinucleotídeo Adenililtransferase/isolamento & purificação , Polinucleotídeo Adenililtransferase/metabolismo , RNA Bacteriano/biossíntese , Rhodospirillum rubrum/crescimento & desenvolvimento , Rifampina/farmacologia , Estreptovaricina/farmacologiaAssuntos
Antibióticos Antineoplásicos/farmacologia , DNA Nucleotidiltransferases/antagonistas & inibidores , Inibidores da Síntese de Ácido Nucleico , Estreptovaricina/farmacologia , Células Cultivadas , Humanos , Leucemia Linfoide/enzimologia , Linfócitos/enzimologia , Naftóis/farmacologia , Quinonas/farmacologiaRESUMO
A series of structurally related ansamycins have been analyzed, in a new immobilized template assay, to determine the mechanism by which they inhibit a ribonucleic acid-directed deoxyribonucleic acid (DNA) polymerase from Moloney murine leukemia virus. By this assay, we can better correlate specific structures of these drugs with inhibitory mechanisms. Using an immobilized template, we were also able to observe drug effects on the stability of complexes formed between the polymerase, a template (polyadenylic acid-agarose), and a primer, as well as to monitor the synthesis of DNA in the presence of drug. For each drug, we determined the complex (intermediate in DNA synthesis) which was primarily affected and whether the effect was due to a destabilization process. Although the activity and specificity of the unsubstituted ansamycins (streptovaricins and rifamycin SV) were modulated by conformation of the molecule and electron density of the aromatic ring, the principal mode of inhibition is, apparently, drug binding to a polymerase-template complex; the drug binds in a manner which prevents subsequent formation of a polymerase-template-primer complex. However, some derivatives of rifamycin SV, when substituted at carbon-3 with bulky or hydrophobic side chains, displayed markedly different modes of action. For example, demethyl dimethyl rifampin prevented the formation of polymerase-template complexes, whereas rifazacyclo 16 acted by promoting the dissociation of polymerase-template-primer complexes.
Assuntos
Antibacterianos/farmacologia , Enzimas Imobilizadas , Inibidores da Síntese de Ácido Nucleico , RNA/fisiologia , Fenômenos Químicos , Química , DNA Polimerase Dirigida por DNA/metabolismo , Lactamas Macrocíclicas , Vírus da Leucemia Murina de Moloney/enzimologia , Rifamicinas/farmacologia , Sefarose , Estreptovaricina/farmacologia , Relação Estrutura-Atividade , Moldes GenéticosRESUMO
An inhibitor of the reverse trascriptase-streptovaricin in a dose of 4 mkg/ml would induce an increase of the DNA amount in L cell nuclei, while its dosage of 8 mkg/ml decrease the amount of DNA, resulting in the differentiation of some population cells. Streptovaricin inhibited the L cell multiplication, rendering no significant effect on that of normal fibroblasts of C3H mice culture.
Assuntos
Células L/efeitos dos fármacos , Estreptovaricina/farmacologia , Animais , Divisão Celular/efeitos dos fármacos , Núcleo Celular/efeitos dos fármacos , Células Cultivadas , DNA/análise , Relação Dose-Resposta a Droga , Camundongos , Camundongos Endogâmicos C3H , Inibidores da Transcriptase Reversa , Fatores de TempoRESUMO
The streptovaricin complex (SvCx) and rifamycin SV derivatives display potent antiviral activity against the polycythemic strain of Friend leukemia virus (FV-P), as measured by a reduction in the number of spleen foci produced in mice. Such reductions may be explained by inactivation of functions of (i) the spleen focus-forming virus (SFFV), (ii) its "helper" murine leukemia virus (MuLV), or (iii) both viruses normally present in FV-P. We noted that preincubation of FV-P with fractionation products of SvCx, or derivatives of rifamycin SV, at low concentrations (3 to 5 mug/ml) reduces the number of spleen foci 80 to 97%, whereas titers of MuLV (from the same inoculum) remain unaffected (MuLV titers were measured by XC, S(+)L(-), and "helper activity" assays). Our findings indicate a remarkable biological selectivity of ansamycins, as well as nonansamycin components of SvCx, against the transforming and defective spleen focus-forming virus as compared to MuLV. Thus, the drugs might be useful in distinguishing other types of oncornaviruses.